IGM Biosciences Inc (IGMS) — Cash Flow Quality Index

Latest as of June 2025: -0.52x

IGM Biosciences Inc (IGMS) has a Cash Flow Quality Index of -0.52x as of June 2025. Operating cash flow of $-50.79 Million is below net income of $97.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore IGM Biosciences Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.52x

Operating CF / Net Income

Operating Cash Flow

$-50.79 Million

USD

Net Income

$97.58 Million

USD

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for IGM Biosciences Inc (None–None)

Year-by-year earnings quality comparison for IGM Biosciences Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.